02/25/2021
Dr. Narayanan and Dr. Liotta testing therapeutic efficacy of potential COVID-19 treatments.
https://www.eurekalert.org/pub_releases/2021-02/gmu-nl021921.php?fbclid=IwAR0evnhLTdkSNYWrbIfMGk8cjuxql2ksY1xheQq4-v1Zeb9rQw8yOENTgDY #
Aarthi Narayanan, Associate Professor, and Lance Liotta, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), are conducting three studies to assess the therapeutic efficacy of candidate interventions for COVID-19 in mouse models.
